SUNPHARMA's weekly return of 0.53% was modest, accompanied by relatively high volatility of 15.9%. The stock's Sharpe Ratio of 0.14 indicates a low risk-adjusted return. Compared to peers, SUNPHARMA underperformed DRREDDY and DIVISLAB, but outperformed HINDUNILVR. Overall, the stock's performance was lackluster, with a moderate level of risk.

[Volatility: 15.9%]